Issue of Convertible Loan Notes

MetalNRG PLC
20 November 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

20 November 2024

MetalNRG plc

(the "Company" or "MetalNRG")

Issue of Convertible Loan Notes

 

MetalNRG (LON:MNRG), the natural resources and energy company, announces that is has raised £475,000 via the issue of convertible loan notes ("CLNs").  The CLNs carry a 15% per annum coupon and are convertible into new ordinary shares in the Company, at a 20% discount to the prevailing share price, upon the earlier of the Company completing a transaction classified as a reverse takeover under Listing Rule 5.6.4 or two years from the date of issue.  The CLNs are also subject to customary events of default.

 

The funds raised through the issue of the CLNs will be used to cover certain transaction costs in relation to the Company's proposed acquisition of Compagnie Minière de l'Oumejrane S.A. ("CMO"), as announced on 17 October 2024, and for general corporate purposes.

 

For further information, please contact:

MetalNRG PLC:

Christopher Chadwick

+44 (0) 207 796 9060

Rolf Gerritsen


Hannam & Partners - Financial Adviser and Joint Broker

Andrew Chubb

+44 (0) 207 907 8500

SPARK Advisory Partners Limited - Sponsor

James Keeshan

+44 (0) 203 368 3550

Andrew Emmott


Peterhouse Capital Limited - Joint Broker:

Lucy Williams

+ 44 (0) 207 469 0930

Duncan Vasey


S I Capital Limited - Joint Broker:

Nick Emerson

+44 (0) 1483 413500

IFC Advisory Limited - Financial PR and IR


Tim Metcalfe

+44 (0) 203 934 6630

Florence Chandler


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings